GOSS
Gossamer BioยทNASDAQ
--
--(--)
--
--(--)
GOSS Profile
Gossamer Bio, Inc.
A clinical-stage biopharmaceutical company that developing therapeutics in the disease areas of immunology, inflammation and oncology
Biological Technology
10/26/2015
02/08/2019
NASDAQ Stock Exchange
161
12-31
Common stock
3115 Merryfield Row, Suite 120, San Diego, California 92121
--
Gossamer Bio, Inc., was incorporated under the laws of the State of Delaware on October 26, 2015. The Company is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension, including pulmonary hypertension and pulmonary hypertension associated with interstitial lung disease. It is led by a management team with extensive experience in leading biopharmaceutical companies.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
